Yale scientists enable massively parallel DNA insertions into human cells

Yale receives renewed lung cancer SPORE grant from NCI

Yale Cancer Center’s Specialized Program of Research Excellence in Lung Cancer was awarded a renewal grant from NCI for year 11 of the program.

September 19, 2025

Vol.51 No.34

In Brief

Tracy Battaglia named associate director of COE at Yale

Tracy Battaglia joined Yale Cancer Center’s Community Outreach and Engagement serving as associate director.

September 12, 2025

Vol.51 No.33

Clinical Roundup

Study uncovers source of genetic variation influencing childhood brain tumors

Researchers at Baylor College of Medicine and collaborating institutions investigated for the first time in cancer the association between two sources of genetic variation: germline or inherited structural variation, which refers to large differences in the DNA sequence, and DNA methylation, which is when genes are turned on or off without altering the DNA code.

May 23, 2025

Vol.51 No.20

Clinical Roundup

Genetic mutation in some Ashkenazi Jewish men may be linked to higher prostate cancer risk, study shows

A Johns Hopkins Medicine-led research team has identified a recurrent frameshift mutation, called F722fs, in the MMS22L gene among men of Ashkenazi Jewish ancestry that is associated with a higher risk of prostate cancer and increased sensitivity to a specific anticancer therapy.

May 23, 2025

Vol.51 No.20

Clinical Roundup

A post-treatment blood test could inform future cancer therapy decisions, study shows

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with lung cancer years after their treatment.

March 21, 2025

Vol.51 No.11

Clinical Roundup

Deadly dog cancer reveals clues for improved treatment, UF study finds

Researchers at the University of Florida College of Veterinary Medicine and the UF Health Cancer Center have identified a crucial link between a gene mutation and immune system signaling in canine hemangiosarcoma, a discovery that could lead to better treatments for both dogs and humans with similar cancers.

January 24, 2025

Vol.51 No.03

Yale scientists enable massively parallel DNA insertions into human cells

YOU MAY BE INTERESTED IN

Yale receives renewed lung cancer SPORE grant from NCI

Tracy Battaglia named associate director of COE at Yale

Study uncovers source of genetic variation influencing childhood brain tumors

Genetic mutation in some Ashkenazi Jewish men may be linked to higher prostate cancer risk, study shows

A post-treatment blood test could inform future cancer therapy decisions, study shows

Deadly dog cancer reveals clues for improved treatment, UF study finds

Renew today!

Subscriber content

Never miss an issue!

Login